Hajra focuses her practice on the representation of public and private pharmaceutical, biotechnology, and other life sciences companies with respect to a variety of intellectual property-based commercial transactions, including licenses and research and development collaborations.

Download full bio 


  • Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion 

  • Poseida Therapeutics Enters Strategic Collaboration and License Agreement With Roche 

  • Bristol Myers Squibb to Acquire Turning Point Therapeutics for $4.1 Billion 

  • Immatics Enters Global Exclusive License Agreement With Bristol Myers Squibb 

  • Nykode Therapeutics Enters Collaboration Agreement with Regeneron 


  • Washington University School of Law
    JD, cum laude, 2019

  • George Washington University
    BA, Political Science

Admissions & Credentials

District of Columbia